In the News

Share
1666 News Items found
Article
MSK head and neck surgeon Marc Cohen and a patient
Questions To Ask an Oncologist During Your First Visit After a Cancer Diagnosis
A cancer diagnosis is life-changing. You might be thinking, “I have cancer, now what?” The first step is to make an appointment with an oncologist — a ...
MSK bile duct cancer patient Berta Pesantez
How MSK Is Making Cancer Clinical Trials in NYC Easier To Access
For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.
Blood samples being prepared for a centrifuge
MSK Research Highlights, ASH Annual Meeting 2022
Numerous developments in cellular therapy, multiple myeloma, leukemia and lymphoma are being presented by Memorial Sloan Kettering Cancer Center (MSK) researchers at the American Society of Hematology (ASH) Annual Meeting, which runs December 10-13.
Ray Hunter participated in the 2022 Summer Pipeline Program at MSK.
Ray Hunter: A Medical Student Determined to Serve His Community
Hear from a medical student that participated in the Office of Health Equity’s Summer Pipeline Program.
MSK Postdoc Siting Gan
Sloan Kettering Institute Postdoc Spotlight: Siting Gan, Massagué and Pe'er Labs
Siting Gan has the heart of a rebel. Although she focused on physics in high school in Beijing, China, where she grew up, and chose to major in physics in college, she knew that she “wanted to do research and discover things myself.” That determination to pursue her own questions led her to biology and, ultimately, to a unique situation at Sloan Kettering Institute (SKI).
MSK robotic Whipple patient Chris Scott and his wife, Kathy
Robotic Whipple Surgery Helps Chris Beat Pancreatic Cancer — Before It Started
When Chris Scott met with his urologist in January 2022, he thought they’d talk about an issue he was having with his prostate. But the conversation to...
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
MSK's Tobias Walther and Robert Farese, Jr.
Renowned Cellular Lipid and Energy Metabolism Researchers Join the Sloan Kettering Institute
Learn about renowned cellular lipid and energy metabolism researchers Robert Farese, Jr., and Tobias Walther who recently joined the Sloan Kettering Institute, running their lab jointly.
In the Clinic
Joyce Tyson
International Study Shows Liquid Biopsies May Improve Lung Cancer Survival
An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies.
Postdocs Francisco “Pancho” Barriga and Kaloyan Tsanov in the lab
New MACHETE Technique Slices Into Cancer Genome To Study Copy Number Alterations
Learn why MSK researchers developed MACHETE, a new CRISPR-based technique to study large-scale genetic deletions efficiently in laboratory models.
MSK thoracic surgeon and lung cancer specialist David Jones.
Inherited BRMS1 Mutation Promotes Lung Cancer Spread, MSK Research Suggests
An inherited mutation that contributes to lung cancer spread could be a target for therapies.
Memorial Sloan Kettering behavioral scientists Jamie Ostroff and Smita Banerjee
Memorial Sloan Kettering Cancer Center Leads Collaborative Effort to End Lung Cancer Related Stigmas
Memorial Sloan Kettering Cancer Center (MSK) is committed to helping eliminate the stigmas associated with a lung cancer diagnosis and is working to raise awareness in close collaboration with other national organizations such as the GO2 Foundation for Lung Cancer and American Cancer Society.
Selwyn M. Vickers, M.D., FACS
Selwyn M. Vickers Named to amNY Metro and PoliticsNY’s Power Players in Healthcare List
The list acknowledges and celebrates healthcare leaders who envision a better future for all New Yorkers and constitute New York’s ever-expanding and constantly improving healthcare system.
Feature
MSK medical oncologist and genitourinary cancer specialist Emily Feld
Interpreting Bladder Cancer Symptoms in Men vs. Women: What You Should Know
Learn what bladder cancer symptoms can mean in men and women.
In the Clinic
Nancy Schroeder and her husband Mark
New Checkpoint Inhibitor Immunotherapy Treatment for Advanced Melanoma Shows Promise
Results from a phase 2 clinical trial report a combination of two checkpoint inhibitor immunotherapy drugs given before melanoma surgery prevents this aggressive skin cancer from coming back. This new drug combination also has fewer side effects than other immunotherapy treatments.
MSK hematologic oncologist Saad Usmani, who specializes in treating multiple myeloma.
FDA Approves Teclistamab, a Promising New Drug for Multiple Myeloma Targeting BCMA and CD3 Proteins
Learn how FDA approval of a new multiple myeloma drug will brighten the outlook for people with resistant forms of the disease.
Medical oncologist Ghassan Abou-Alfa led the clinical trial that resulted in the FDA’s approval of a new combination therapy for hepatocellular cancer.
FDA Approves New Immunotherapy Combination To Treat Advanced Liver Cancer
Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.
Rachel Samuels Rand (l) with her husband, Brendan Rand.
3-D Nipple Tattoos After Breast Cancer Surgery: An MSK Specialty
Learn how specialists at Memorial Sloan Kettering tattoo highly realistic nipples and areolas on people who have had them removed during surgery for breast cancer.
Memorial Sloan Kettering breast cancer patient Linda Dow
When Breast Cancer Surgery Isn’t an Option, Cryoablation Can Offer Hope
Learn about cryoablation for breast cancer at Memorial Sloan Kettering Cancer Center.
A slide being reviewed under a microscope
MSK Research Highlights, October 13, 2022
New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute suggests a therapeutic strategy to overcome resistance to PRMT5 inhibition in lymphoma; finds safety and clinical benefit using an engineered adenovirus in combination with immunotherapy against PD-1-resistant melanoma; and uncovers a new type of immune cell that plays a key role in establishing a healthy gut microbiome.